Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 07, 2021 Filed Jun 8, 2021 20:48 UTC |
Finke Daniel PEVP/Pres, Health Care Benefits
|
SaleCommon Stock | 37,594 | $86.60 | $3,255,640.40 |
DisclosureSEC source: 0001127602-21-019437 · form4.xml · nonDerivative · entry 2 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,309.5841 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging from $86.52 and $86.71 per share. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 20:48 UTC |
Finke Daniel PEVP/Pres, Health Care Benefits
|
Exercise / conversionCommon Stock | 32,320 | $54.19 | $1,751,420.80 |
DisclosureSEC source: 0001127602-21-019437 · form4.xml · nonDerivative · entry 1 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,903.5841 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2021 Filed Jun 2, 2021 20:56 UTC |
MERLO LARRY JDirector
|
Tax withholdingCommon Stock | 634 | $86.44 | $54,802.96 |
DisclosureSEC source: 0001127602-21-018738 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 632,312.9407 F1 · shares: Surrender of shares in payment of FICA taxes due upon retirement. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 20:59 UTC |
GUERTIN SHAWN MEVP & Chief Financial Officer
|
GrantStock Option · Derivative | 97,562 | $86.44 Strike: $1.00 | $8,433,259.28 |
DisclosureSEC source: 0001127602-21-018741 · form4.xml · derivative · entry 3 GUERTIN SHAWN M · CIK 0001231553 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,562 Underlying: Common Stock · 97,562 shares Expires 2031-05-28 F2 · shares: Option becomes exercisable in four equal annual installments, commencing 5/28/2022. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 20:59 UTC |
GUERTIN SHAWN MEVP & Chief Financial Officer
|
GrantCommon Stock (restricted) | 34,706 | $86.44 | $2,999,986.64 |
DisclosureSEC source: 0001127602-21-018741 · form4.xml · nonDerivative · entry 1 GUERTIN SHAWN M · CIK 0001231553 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,706 F1 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse 5/28/2024. Read SEC document |
| May 13, 2021 Filed May 14, 2021 20:58 UTC |
BROWN C DAVID IIDirector
|
GrantShare Credits · Derivative | 1,957.9922 | $84.27 Strike: $0.00 | $165,000.00 |
DisclosureSEC source: 0001127602-21-016870 · form4.xml · derivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,866.572 Underlying: Common Stock · 1,957.9922 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 13, 2021 Filed May 14, 2021 21:09 UTC |
DECOUDREAUX ALECIA ADirector
|
GrantShare Credits · Derivative | 1,379.4945 | $84.27 Strike: $0.00 | $116,250.00 |
DisclosureSEC source: 0001127602-21-016880 · form4.xml · derivative · entry 2 DECOUDREAUX ALECIA A · CIK 0001233354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,599.338 Underlying: Common Stock · 1,379.4945 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 13, 2021 Filed May 14, 2021 21:12 UTC |
LUDWIG EDWARD JDirector
|
GrantShare Credits · Derivative | 1,490.744 | $84.27 Strike: $0.00 | $125,625.00 |
DisclosureSEC source: 0001127602-21-016884 · form4.xml · derivative · entry 3 LUDWIG EDWARD J · CIK 0001221783 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,586.6592 Underlying: Common Stock · 1,490.744 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 13, 2021 Filed May 14, 2021 21:10 UTC |
FARAH ROGER NDirector
|
GrantShare Credits · Derivative | 1,839.326 | $84.27 Strike: $0.00 | $155,000.00 |
DisclosureSEC source: 0001127602-21-016882 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,087.2977 Underlying: Common Stock · 1,839.326 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 13, 2021 Filed May 14, 2021 21:13 UTC |
SCHAPIRO MARY LDirector
|
GrantShare Credits · Derivative | 1,379.4945 | $84.27 Strike: $0.00 | $116,250.00 |
DisclosureSEC source: 0001127602-21-016886 · form4.xml · derivative · entry 2 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,230.7911 Underlying: Common Stock · 1,379.4945 shares Expires not disclosed F2 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F3 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F3 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 13, 2021 Filed May 14, 2021 21:13 UTC |
SCHAPIRO MARY LDirector
|
GrantCommon Stock | 459 | $84.27 | $38,679.93 |
DisclosureSEC source: 0001127602-21-016886 · form4.xml · nonDerivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,168 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 13, 2021 Filed May 14, 2021 21:16 UTC |
WELDON WILLIAM CDirector
|
GrantShare Credits · Derivative | 1,839.326 | $84.27 Strike: $0.00 | $155,000.00 |
DisclosureSEC source: 0001127602-21-016892 · form4.xml · derivative · entry 2 WELDON WILLIAM C · CIK 0001189019 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,360.5738 Underlying: Common Stock · 1,839.326 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 13, 2021 Filed May 14, 2021 21:18 UTC |
AGUIRRE FERNANDODirector
|
GrantCommon Stock | 1,379 | $84.27 | $116,208.33 |
DisclosureSEC source: 0001127602-21-016895 · form4.xml · nonDerivative · entry 1 AGUIRRE FERNANDO · CIK 0001224983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,991 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 13, 2021 Filed May 14, 2021 21:21 UTC |
DEPARLE NANCY ANNDirector
|
GrantCommon Stock | 1,468 | $84.27 | $123,708.36 |
DisclosureSEC source: 0001127602-21-016899 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,068 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 13, 2021 Filed May 14, 2021 21:22 UTC |
DORMAN DAVID WDirector
|
GrantCommon Stock | 3,470 | $84.27 | $292,416.90 |
DisclosureSEC source: 0001127602-21-016901 · form4.xml · nonDerivative · entry 1 DORMAN DAVID W · CIK 0001082870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,670 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 13, 2021 Filed May 14, 2021 21:23 UTC |
Finucane Anne A.Director
|
GrantCommon Stock | 1,446 | $84.27 | $121,854.42 |
DisclosureSEC source: 0001127602-21-016902 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,446 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 13, 2021 Filed May 14, 2021 21:26 UTC |
MILLON JEAN PIERREDirector
|
GrantCommon Stock | 1,379 | $84.27 | $116,208.33 |
DisclosureSEC source: 0001127602-21-016905 · form4.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,379 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 13, 2021 Filed May 14, 2021 21:28 UTC |
WHITE TONY LDirector
|
GrantCommon Stock | 1,446 | $84.27 | $121,854.42 |
DisclosureSEC source: 0001127602-21-016906 · form4.xml · nonDerivative · entry 1 WHITE TONY L · CIK 0001171315 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,500 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:30 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionStock Option · Derivative | 109,469 | $0.00 Strike: $62.21 | $0.00 |
DisclosureSEC source: 0001127602-21-016436 · form4.xml · derivative · entry 6 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,490 Underlying: Common Stock · 109,469 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2019. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:30 UTC |
Moriarty Thomas MEVP & General Counsel
|
SaleCommon Stock | 109,469 | $86.00 | $9,414,334.00 |
DisclosureSEC source: 0001127602-21-016436 · form4.xml · nonDerivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| May 10, 2021 Filed May 12, 2021 21:30 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionCommon Stock | 109,469 | $62.21 | $6,810,066.49 |
DisclosureSEC source: 0001127602-21-016436 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2021 Filed May 10, 2021 21:18 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
SaleCommon Stock | 9,477 | $84.00 | $796,068.00 |
DisclosureSEC source: 0001127602-21-016099 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,697.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| May 04, 2021 Filed May 6, 2021 21:52 UTC |
Boratto Eva CEVP & CFO
|
SaleCommon Stock | 4,905 | $80.00 | $392,400.00 |
DisclosureSEC source: 0001127602-21-015775 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,331.0445 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| May 04, 2021 Filed May 6, 2021 21:53 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionStock Option · Derivative | 49,279 | $0.00 Strike: $58.34 | $0.00 |
DisclosureSEC source: 0001127602-21-015776 · form4.xml · derivative · entry 5 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,837 Underlying: Common Stock · 49,279 shares Expires 2030-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The number of shares subject to the option were calculated using a 30-day average price. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2021. Read SEC document |
| May 04, 2021 Filed May 6, 2021 21:53 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionCommon Stock | 49,279 | $58.34 | $2,874,936.86 |
DisclosureSEC source: 0001127602-21-015776 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,279 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 21, 2021 Filed Apr 23, 2021 20:57 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionStock Option · Derivative | 101,003 | $0.00 Strike: $54.19 | $0.00 |
DisclosureSEC source: 0001127602-21-014345 · form4.xml · derivative · entry 7 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,004 Underlying: Common Stock · 101,003 shares Expires 2029-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2020. Read SEC document |
| April 21, 2021 Filed Apr 23, 2021 20:57 UTC |
Moriarty Thomas MEVP & General Counsel
|
SaleCommon Stock | 2,420 | $77.00 | $186,340.00 |
DisclosureSEC source: 0001127602-21-014345 · form4.xml · nonDerivative · entry 3 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: All sales were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| April 21, 2021 Filed Apr 23, 2021 20:57 UTC |
Moriarty Thomas MEVP & General Counsel
|
SaleCommon Stock | 101,003 | $77.00 | $7,777,231.00 |
DisclosureSEC source: 0001127602-21-014345 · form4.xml · nonDerivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,420 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 21, 2021 Filed Apr 23, 2021 20:57 UTC |
Moriarty Thomas MEVP & General Counsel
|
Exercise / conversionCommon Stock | 101,003 | $54.19 | $5,473,352.57 |
DisclosureSEC source: 0001127602-21-014345 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,423 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2021 Filed Apr 5, 2021 21:38 UTC |
Lotvin AlanEVP&President-PharmacyServices
|
Tax withholdingCommon Stock | 1,705 | $74.30 | $126,681.50 |
DisclosureSEC source: 0001127602-21-013214 · form4.xml · nonDerivative · entry 1 Lotvin Alan · CIK 0001472795 · EVP&President-PharmacyServices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,828.6756 F1 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 3, 2021. Read SEC document |
| April 03, 2021 Filed Apr 5, 2021 21:39 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 480 | $74.30 | $35,664.00 |
DisclosureSEC source: 0001127602-21-013218 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,497.2554 F1 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 3, 2021. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 20:57 UTC |
Bisaccia LisaFormer EVP & Chief HR Officer
|
Tax withholdingCommon Stock | 1,190 | $74.30 | $88,417.00 |
DisclosureSEC source: 0001127602-21-012689 · form4.xml · nonDerivative · entry 3 Bisaccia Lisa · CIK 0001479663 · Former EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,417 F3 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 1, 2021. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 20:57 UTC |
Bisaccia LisaFormer EVP & Chief HR Officer
|
Tax withholdingCommon Stock | 35,120 | $74.30 | $2,609,416.00 |
DisclosureSEC source: 0001127602-21-012689 · form4.xml · nonDerivative · entry 2 Bisaccia Lisa · CIK 0001479663 · Former EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,983 F2 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 20:59 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
GrantStock Option · Derivative | 99,344 | $74.30 Strike: $74.30 | $7,381,259.20 |
DisclosureSEC source: 0001127602-21-012693 · form4.xml · derivative · entry 5 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,344 Underlying: Common Stock · 99,344 shares Expires 2031-04-01 F4 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2022. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 20:59 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
Tax withholdingCommon Stock | 1,623 | $74.30 | $120,588.90 |
DisclosureSEC source: 0001127602-21-012693 · form4.xml · nonDerivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,174.059 F3 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 1, 2021. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 20:59 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
Tax withholdingCommon Stock | 42,855 | $74.30 | $3,184,126.50 |
DisclosureSEC source: 0001127602-21-012693 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,219.059 F2 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:00 UTC |
Boratto Eva CEVP & CFO
|
GrantStock Option · Derivative | 103,663 | $74.30 Strike: $74.30 | $7,702,160.90 |
DisclosureSEC source: 0001127602-21-012695 · form4.xml · derivative · entry 5 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,663 Underlying: Common Stock · 103,663 shares Expires 2031-04-01 F4 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2022. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:00 UTC |
Boratto Eva CEVP & CFO
|
Tax withholdingCommon Stock | 649 | $74.30 | $48,220.70 |
DisclosureSEC source: 0001127602-21-012695 · form4.xml · nonDerivative · entry 3 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,236.0445 F3 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 1, 2021. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:00 UTC |
Boratto Eva CEVP & CFO
|
Tax withholdingCommon Stock | 40,128 | $74.30 | $2,981,510.40 |
DisclosureSEC source: 0001127602-21-012695 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,454.0445 F2 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:06 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
GrantStock Option · Derivative | 12,094 | $74.30 Strike: $74.30 | $898,584.20 |
DisclosureSEC source: 0001127602-21-012713 · form4.xml · derivative · entry 5 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,094 Underlying: Common Stock · 12,094 shares Expires 2031-04-01 F5 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2022. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:06 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
GrantCommon Stock (restricted) | 4,710 | $74.30 | $349,953.00 |
DisclosureSEC source: 0001127602-21-012713 · form4.xml · nonDerivative · entry 4 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,046 F4 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2022. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:06 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 1,503 | $74.30 | $111,672.90 |
DisclosureSEC source: 0001127602-21-012713 · form4.xml · nonDerivative · entry 3 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,920.2554 F3 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 1, 2021. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:06 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 5,246 | $74.30 | $389,777.80 |
DisclosureSEC source: 0001127602-21-012713 · form4.xml · nonDerivative · entry 2 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,111.2554 F2 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:10 UTC |
Finke Daniel PEVP/Pres, Health Care Benefits
|
GrantStock Option · Derivative | 82,066 | $74.30 Strike: $74.30 | $6,097,503.80 |
DisclosureSEC source: 0001127602-21-012728 · form4.xml · derivative · entry 6 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,066 Underlying: Common Stock · 82,066 shares Expires 2031-04-01 F4 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2022. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:10 UTC |
Finke Daniel PEVP/Pres, Health Care Benefits
|
Tax withholdingCommon Stock | 4,540 | $74.30 | $337,322.00 |
DisclosureSEC source: 0001127602-21-012728 · form4.xml · nonDerivative · entry 3 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,565.1519 F3 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 1, 2021. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:10 UTC |
Finke Daniel PEVP/Pres, Health Care Benefits
|
Tax withholdingCommon Stock | 6,044 | $74.30 | $449,069.20 |
DisclosureSEC source: 0001127602-21-012728 · form4.xml · nonDerivative · entry 2 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,309.1519 F2 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:12 UTC |
Havanec Laurie P.EVP and Chief People Officer
|
GrantStock Option · Derivative | 27,643 | $74.30 Strike: $74.30 | $2,053,874.90 |
DisclosureSEC source: 0001127602-21-012741 · form4.xml · derivative · entry 3 Havanec Laurie P. · CIK 0001807757 · EVP and Chief People Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,643 Underlying: Common Stock · 27,643 shares Expires 2031-04-01 F1 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2022. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:16 UTC |
Lotvin AlanEVP&President-PharmacyServices
|
GrantStock Option · Derivative | 120,940 | $74.30 Strike: $74.30 | $8,985,842.00 |
DisclosureSEC source: 0001127602-21-012762 · form4.xml · derivative · entry 6 Lotvin Alan · CIK 0001472795 · EVP&President-PharmacyServices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,940 Underlying: Common Stock · 120,940 shares Expires 2031-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2022. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:16 UTC |
Lotvin AlanEVP&President-PharmacyServices
|
Tax withholdingCommon Stock | 42,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-012762 · form4.xml · nonDerivative · entry 2 Lotvin Alan · CIK 0001472795 · EVP&President-PharmacyServices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,690.6756 F2 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 21:20 UTC |
Lynch Karen SEVP and President, Aetna
|
GrantStock Option · Derivative | 224,604 | $74.30 Strike: $74.30 | $16,688,077.20 |
DisclosureSEC source: 0001127602-21-012769 · form4.xml · derivative · entry 5 Lynch Karen S · CIK 0001333760 · EVP and President, Aetna 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,604 Underlying: Common Stock · 224,604 shares Expires 2031-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.